Literature DB >> 12214061

Constitutive Wee1 activity in adult brain neurons with M phase-type alterations in Alzheimer neurodegeneration.

Andrei Tomashevski1, Jacob Husseman, Lee-Way Jin, David Nochlin, Inez Vincent.   

Abstract

The cdc2/cyclin B1 kinase is absent from neurons that are terminally differentiated. However, unscheduled activation of Cdc2/cyclin B and accumulation of mitotic phosphoepitopes have been described in degenerating neurons of Alzheimer's disease (AD), and their appearance precedes hallmark lesion formation. In cycling cells the timing of cdc2 activation and onset of mitosis are determined by the Wee1 tyrosine kinase. We therefore investigated the Wee1 kinase in human brain. Surprisingly, we have found that the enzyme is constitutively active in neurons of normal brain. Consistent with its behavior in M phase, Wee1 in AD has decreased activity, becomes MPM-2 immunoreactive, and is redistributed from its normally nuclear domain to the cytoplasm of affected neurons. These data suggest that Wee1 functions in normal postmitotic neurons, but is altered in AD so as to promote activation of Cdc2/cyclin B1. Thus, Wee1 is yet another mitotic regulator that participates in the AD neurodegenerative process.

Entities:  

Year:  2001        PMID: 12214061     DOI: 10.3233/jad-2001-3205

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

Review 1.  Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.

Authors:  Chinthalapally V Rao; Mudassir Farooqui; Adam S Asch; Hiroshi Y Yamada
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

2.  Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation.

Authors:  Nathalie L Chevallier; Salvador Soriano; David E Kang; Eliezer Masliah; Gloria Hu; Edward H Koo
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

3.  Dissecting the M phase-specific phosphorylation of serine-proline or threonine-proline motifs.

Authors:  Chuan Fen Wu; Ruoning Wang; Qianjin Liang; Jianjiao Liang; Wenke Li; Sung Yun Jung; Jun Qin; Sue-Hwa Lin; Jian Kuang
Journal:  Mol Biol Cell       Date:  2010-03-10       Impact factor: 4.138

4.  Cell-cycle markers in a transgenic mouse model of human tauopathy: increased levels of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1.

Authors:  Patrice Delobel; Isabelle Lavenir; Bernardino Ghetti; Max Holzer; Michel Goedert
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

5.  Brain-derived neurotrophic factor-dependent cdk1 inhibition prevents G2/M progression in differentiating tetraploid neurons.

Authors:  María C Ovejero-Benito; José M Frade
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

6.  A novel multiplex cell viability assay for high-throughput RNAi screening.

Authors:  Daniel F Gilbert; Gerrit Erdmann; Xian Zhang; Anja Fritzsche; Kubilay Demir; Andreas Jaedicke; Katja Muehlenberg; Erich E Wanker; Michael Boutros
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

7.  Targeting gonadotropins: an alternative option for Alzheimer disease treatment.

Authors:  Gemma Casadesus; Emma Ramiro Puig; Kate M Webber; Craig S Atwood; Margarida Castell Escuer; Richard L Bowen; George Perry; Mark A Smith
Journal:  J Biomed Biotechnol       Date:  2006

Review 8.  Neuronal cell cycle: the neuron itself and its circumstances.

Authors:  José M Frade; María C Ovejero-Benito
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

9.  Identifying a kinase network regulating FGF14:Nav1.6 complex assembly using split-luciferase complementation.

Authors:  Wei-Chun Hsu; Miroslav N Nenov; Alexander Shavkunov; Neli Panova; Ming Zhan; Fernanda Laezza
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

10.  Inhibition of AKT Signaling Alters βIV Spectrin Distribution at the AIS and Increases Neuronal Excitability.

Authors:  Jessica Di Re; Wei-Chun J Hsu; Cihan B Kayasandik; Nickolas Fularczyk; T F James; Miroslav N Nenov; Pooran Negi; Mate Marosi; Federico Scala; Saurabh Prasad; Demetrio Labate; Fernanda Laezza
Journal:  Front Mol Neurosci       Date:  2021-06-30       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.